Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001973
Filing Date
2025-01-23
Accepted
2025-01-23 18:24:29
Documents
1
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 form4-01232025_110125.html 4  
1 form4-01232025_110125.xml 4 3931
  Complete submission text file 0001415889-25-001973.txt   5373
Mailing Address C/O SIERRA ONCOLOGY, INC. 1820 GATEWAY DRIVE, SUITE 110 SAN MATEO CA 94404
Business Address
Klencke Barbara (Reporting) CIK: 0001647647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39386 | Film No.: 25551228

Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Issuer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)